Richard Payerchin

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

Rep. Greg Murphy, MD, discusses his bill to stop the planned Medicare reimbursement reduction.

Ferguson, who opposed ban of noncompetes, named to succeed Chair Khan; new commissioner Meador called for PBM regulations.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

Monthly report shows gains for hospitals, home health care services.

How is life different across the pond? UK babies can expect to live longer than newborn Americans.

The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

The Commonwealth Fund compares United States with other developed nations.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Lawmaker discusses state of the nation’s physician workforce – and the rise of part-time practice.

‘Old guys are taking ER call’ as younger docs ponder medicine as a calling, or just a job.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

The clock is ticking for lawmakers to approve policies that could affect U.S. health care.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Institutional leaders want to standardize practices, but flexibility may be a key to keeping doctors.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Proposals would require more public data on prior authorization processes and whether those advance health equity.

Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.